Effect of Ligustrazine on Nnos Expression in Different Encephalic Regions after Focal Cerebral Ischemia in Adult Rats
邱芬,刘勇,马波,祁存芳,王文静
2009-01-01
Abstract:Objective To observe the expression of neuronal nitric oxide synthase(nNOS) in different encephalic regions and at different time points after focal cerebral ischemia in adult rats and explore the effect of Ligustrazine on nNOS expression.Methods SD male adult rats were randomly divided into five groups: sham operation,ischemic model,low dose(20mg/kg),medium dose(40mg/kg) and high dose(80mg/kg) Ligustrazine groups.According to the time after ischemia,each group was further divided into 5 sub-groups: 1,3,7,14,and 21d(3 rats in each sub-group).Middle cerebral artery occlusion(MCAO) model was established by placement of an intraluminal filament at the origin of MCA.Ligustrazine was administered intraperitoneally at a daily dose of 20,40 or 80mg/kg starting at 2h after MCAO,respectively,until 2h before sacrifice.Immunohistochemical staining was adopted to observe nNOS expression in subventricular zone(SVZ) of the lateral cerebral ventricle,corpus callosum(CC),striatum and cortex peri-infarction,CA1 area,and dentate gyrus(DG).Results Expression of nNOS at different time points was similar in sham operation group,with no significant difference(P0.05).In SVZ,nNOS expression in ischemic model group was reduced on days 1-14,but increased on day 21;after Ligustrazine administration,nNOS expression was obviously decreased on days 3-14 in all Ligustrazine dose groups,but began to increase on day 21.In CC,nNOS expression in ischemic model group was reduced on days 3-14,and began to increase on day 21;in the different-dose Ligustrazine groups,nNOS expression was significantly decreased on days 3-14,especially in medium-and high-dose groups,but increased on day 21.In striatum and cortex peri-infarction,nNOS expression in ischemic model group was obviously decreased on days 3 and 7,but enhanced on days 14 and 21;in various-dose Ligustrazine groups,nNOS expression was decreased on days 3-21,especially in medium-and high-dose groups,but increased slightly on day 21.In DG and CA1 areas,nNOS expression in ischemic model group was reduced on days 3 and 7,but began to increase on day 14;nNOS expression in all Ligustrazine groups were decreased during 3-21d.There were significant differences between ischemic model group and different-dose Ligustrazine groups at different time points(P0.05).Conclusion Ligustrazine has a significantly inhibitory effect on nNOS expression in different encephalic regions during 3-14d after focal cerebral ischemia,suggesting that Ligustrazine might play a brain-protecting role by inhibiting nNOS expression and reducing NO production.